COSCIENS Biopharma Statistics
Total Valuation
CSCI has a market cap or net worth of $11.17 million. The enterprise value is -$3.36 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSCI has 3.15 million shares outstanding. The number of shares has increased by 39.74% in one year.
| Current Share Class | 3.15M |
| Shares Outstanding | 3.15M |
| Shares Change (YoY) | +39.74% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.17 |
| Forward PS | n/a |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.32 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -77.07 |
Financial Efficiency
Return on equity (ROE) is -89.54% and return on invested capital (ROIC) is -32.53%.
| Return on Equity (ROE) | -89.54% |
| Return on Assets (ROA) | -21.13% |
| Return on Invested Capital (ROIC) | -32.53% |
| Return on Capital Employed (ROCE) | -35.70% |
| Revenue Per Employee | $239,675 |
| Profits Per Employee | -$382,725 |
| Employee Count | 40 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, CSCI has paid $84,000 in taxes.
| Income Tax | 84,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.49% in the last 52 weeks. The beta is 2.27, so CSCI's price volatility has been higher than the market average.
| Beta (5Y) | 2.27 |
| 52-Week Price Change | -54.49% |
| 50-Day Moving Average | 3.07 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 58.10 |
| Average Volume (20 Days) | 3,407 |
Short Selling Information
The latest short interest is 24,858, so 0.79% of the outstanding shares have been sold short.
| Short Interest | 24,858 |
| Short Previous Month | 23,826 |
| Short % of Shares Out | 0.79% |
| Short % of Float | 0.87% |
| Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, CSCI had revenue of $9.59 million and -$15.31 million in losses. Loss per share was -$5.93.
| Revenue | 9.59M |
| Gross Profit | 4.73M |
| Operating Income | -9.94M |
| Pretax Income | -18.05M |
| Net Income | -15.31M |
| EBITDA | -8.68M |
| EBIT | -9.94M |
| Loss Per Share | -$5.93 |
Full Income StatementBalance Sheet
The company has $16.39 million in cash and $2.31 million in debt, giving a net cash position of $14.08 million or $4.48 per share.
| Cash & Cash Equivalents | 16.39M |
| Total Debt | 2.31M |
| Net Cash | 14.08M |
| Net Cash Per Share | $4.48 |
| Equity (Book Value) | 13.16M |
| Book Value Per Share | 4.19 |
| Working Capital | 16.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.57 million and capital expenditures -$1.16 million, giving a free cash flow of -$15.73 million.
| Operating Cash Flow | -14.57M |
| Capital Expenditures | -1.16M |
| Free Cash Flow | -15.73M |
| FCF Per Share | -$5.00 |
Full Cash Flow StatementMargins
Gross margin is 49.33%, with operating and profit margins of -103.70% and -159.68%.
| Gross Margin | 49.33% |
| Operating Margin | -103.70% |
| Pretax Margin | -158.81% |
| Profit Margin | -159.68% |
| EBITDA Margin | -90.52% |
| EBIT Margin | -103.70% |
| FCF Margin | n/a |